CA2865242C - Echantillonnage de biomarqueurs dans le contexte de dispositifs de neuromodulation et systemes et procedes associes - Google Patents

Echantillonnage de biomarqueurs dans le contexte de dispositifs de neuromodulation et systemes et procedes associes

Info

Publication number
CA2865242C
CA2865242C CA2865242A CA2865242A CA2865242C CA 2865242 C CA2865242 C CA 2865242C CA 2865242 A CA2865242 A CA 2865242A CA 2865242 A CA2865242 A CA 2865242A CA 2865242 C CA2865242 C CA 2865242C
Authority
CA
Canada
Prior art keywords
neuromodulation
sampling
catheter
renal
energy delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2865242A
Other languages
English (en)
Other versions
CA2865242A1 (fr
Inventor
Rudy Beasley
Ayala Hezi-Yamit
Susan Thornton Edwards
Lori Garcia
Michele Lee Silver
Christopher W. Storment
Carol M. Sullivan
Joseph A. Traina
Stefan Stoyanov Tunev
Original Assignee
Medtronic Ardian Luxembourg SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Ardian Luxembourg SARL filed Critical Medtronic Ardian Luxembourg SARL
Priority claimed from PCT/US2013/030041 external-priority patent/WO2013134733A2/fr
Publication of CA2865242A1 publication Critical patent/CA2865242A1/fr
Application granted granted Critical
Publication of CA2865242C publication Critical patent/CA2865242C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des méthodes permettant de traiter un patient par neuromodulation rénale thérapeutique ainsi que des dispositifs, des systèmes et des procédés associés. Un aspest de l'invention concerne l'échantillonnage de biomarqueurs dans le contexte de dispositifs, de systèmes et de procédés de neuromodulation. Certains modes de réalisation, par exemple, concernent des cathéters, des systèmes de cathéters et des procédés permettant d'échantillonner des biomarqueurs qui changent en réponse à la neuromodulation. Un système peut comprendre, par exemple, une tige allongée et un ensemble de neuromodulation et échantillonnage comprenant un élément de neuromodulation et un élément d'échantillonnage.
CA2865242A 2012-03-08 2013-03-08 Echantillonnage de biomarqueurs dans le contexte de dispositifs de neuromodulation et systemes et procedes associes Active CA2865242C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261608625P 2012-03-08 2012-03-08
US201261608626P 2012-03-08 2012-03-08
US61/608,625 2012-03-08
US61/608,626 2012-03-08
US201261746528P 2012-12-27 2012-12-27
US61/746,528 2012-12-27
PCT/US2013/030041 WO2013134733A2 (fr) 2012-03-08 2013-03-08 Échantillonnage de biomarqueurs dans le contexte de dispositifs de neuromodulation et systèmes et procédés associés.

Publications (2)

Publication Number Publication Date
CA2865242A1 CA2865242A1 (fr) 2013-09-12
CA2865242C true CA2865242C (fr) 2026-01-20

Family

ID=

Similar Documents

Publication Publication Date Title
US12491364B2 (en) Monitoring of neuromodulation using biomarkers
US12257433B2 (en) Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US11779392B2 (en) Methods and devices for localized disease treatment by ablation
Lakhtakia Therapy of pancreatic neuroendocrine tumors: fine needle intervention including ethanol and radiofrequency ablation
US9943354B2 (en) Methods and devices for localized inhibition of inflammation by ablation
Yuan et al. Expression of ghrelin and its receptor in rats after coronary artery ligation
Schrump Circulating tumor DNA: Solid data from liquid biopsies
Pavlova et al. PP. 42.24: association of renin-angiotensin-aldosterone system gene polymorphisms with left ventricular hypertrophy in hypertensive patients
Sun et al. Blocking Axonal Transportation of Neurotrophin Prevents Myocardial Infarction Induced Sympathetic and Cardiac Remodeling
Davidson et al. Research Article Vascular and Neural Dysfunctions in Obese Zucker Rats: Effect of AVE7688